13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001569241
Total reported value
$800.9M
$800.9M
40 檔
29.5%
During the Q1 2024 filing period, Newtyn Management, LLC (CIK: 0001569241) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $800.9M across 40 reported positions.
During Q1 2024, Newtyn Management, LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | PPLI | People Inc | Stock-Comm Services | 15.12% | — | +17.54% | |
| 2 | PAR | Par Technology Corp/del | Stock-Other | 11.27% | +1.37% | +3.22% | |
| 3 | CNNE | Cannae Holdings Inc | Stock-Other | 9.37% | +1.73% | -38.34% | |
| 4 | VTOL | Bristow Group Inc | Stock-Other | 5.82% | — | +24.42% | |
| 5 | MACKEUR | Merrimack Pharmaceuticals In | Stock-Other | 5.51% | — | — | |
| 6 | AIV | Apartment Invt & Mgmt Co -a | Stock-Other | 4.89% | -0.79% | +77.58% | |
| 7 | CCOI | Cogent Communications Holdin | Stock-Other | 4.88% | -0.35% | — | |
| 8 | SPB | Spectrum Brands Holdings Inc | Stock-Other | 4.43% | +0.52% | — | |
| 9 | CIO | City Office Reit Inc | Stock-Other | 3.98% | — | +19.82% | |
| 10 | OFIX | Orthofix Medical Inc | Stock-Other | 3.68% | — | +20.71% | |
| 11 | MITK | Mitek Systems Inc | Stock-Other | 3.25% | — | +16.73% | |
| 12 | TBPH | Theravance Biopharma, Inc. | Stock-Other | 2.94% | -1.11% | -13.48% | |
| 13 | MBI | Mbia Inc | Stock-Other | 2.52% | — | — | |
| 14 | CLFD | Clearfield Inc | Stock-Other | 2.46% | — | — | |
| 15 | LKFT | Lakefront Biotherapeutic-adr | Stock-Other | 2.35% | — | +67.82% | |
| 16 | PPHMEUR | Avid Bioservices Inc | Stock-Other | 2.00% | — | — | |
| 17 | NODK | Ni Holdings Inc | Stock-Other | 1.83% | +0.39% | +13.99% | |
| 18 | BVFL | BV Financial Inc | Stock-Other | 1.79% | — | -12.86% | |
| 19 | STHO | Star Holdings | Stock-Other | 1.23% | — | +7.18% | |
| 20 | FET 9 08-04-25Bond | Forum Energy Technologie | Bond | 1.09% | — | — | |
| 21 | FBTC | Fidelity Wise Origin Bitcoin | ETF-Crypto | 1.08% | — | — | |
| 22 | KOD | Kodiak Sciences Inc | Stock-Other | 1.05% | — | -43.54% | |
| 23 | ASTL | Algoma Steel Group Inc | Stock-Other | 1.00% | — | — | |
| 24 | PCG | P G & E CORP | Stock-Utilities | 0.90% | — | — | |
| 25 | FET | Forum Energy Technologies In | Stock-Other | 0.77% | — | — | |
| 26 | WVE | Wave Life Sciences Ltd. | Stock-Other | 0.61% | -0.07% | -1.96% | |
| 27 | ETNBGBP | 89bio Inc | Stock-Other | 0.58% | — | -8.26% | |
| 28 | ✓ | Mural Oncology Pub LTD Co | Stock-Other | 0.49% | — | +12.36% | |
| 29 | BOLT1EUR | Bolt Biotherapeutics Inc | Stock-Other | 0.47% | — | +9.43% | |
| 30 | ADPT | Adaptive Biotechnologies | Stock-Other | 0.40% | — | +93.69% | |
| 31 | PHAT | Phathom Pharmaceuticals Inc | Stock-Other | 0.35% | — | -74.49% | |
| 32 | OLMA | Olema Pharmaceuticals Inc | Stock-Other | 0.34% | — | — | |
| 33 | AVIR | Atea Pharmaceuticals Inc | Stock-Other | 0.32% | — | -21.33% | |
| 34 | ✓ | Stock-Other | 0.29% | — | -59.08% | ||
| 35 | VNDA | Vanda Pharmaceuticals Inc | Stock-Other | 0.25% | — | +7.24% | |
| 36 | ✓ | Aligos Therapeutics Inc | Stock-Other | 0.23% | — | -4.38% | |
| 37 | SNSEEUR | Sensei Biotherapeutics Inc | Stock-Other | 0.19% | — | -40.83% | |
| 38 | AVU0 | Adverum Biotechnologies Inc | Stock-Other | 0.13% | — | — | |
| 39 | BDTX | Black Diamond Therapeutics I | Stock-Other | 0.13% | — | -55.36% | |
| 40 | LFLYW | Merida Merger CORP I -cw26 | Stock-Other | — | — | — |
According to official SEC Form 13F filings, Newtyn Management, LLC reported a total U.S. public equity portfolio value of $800.9M across 40 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including PPLI, PAR, CNNE) accounted for 29.5% of total reported equity market value during Q1 2024.
During Q1 2024, Newtyn Management, LLC's top holdings by market value included PPLI (15.1%)、PAR (11.3%)、CNNE (9.4%). The largest single position, PPLI, represented 15.1% of total portfolio value.
In Q1 2024, Newtyn Management, LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.